Holen Sie sich die Stockscreener-App
13.91
0.22%
-0.0899
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CYRX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$14.00
Offen:
$14.08
24-Stunden-Volumen:
323.02K
Relative Volume:
0.60
Marktkapitalisierung:
$701.60M
Einnahmen:
$176.18M
Nettoeinkommen (Verlust:
$-36.26M
KGV:
-14.92
EPS:
-0.9326
Netto-Cashflow:
$-28.09M
1W Leistung:
+7.21%
1M Leistung:
+31.91%
6M Leistung:
+45.52%
1J Leistung:
+131.28%
1-Tages-Spanne:
$13.91
$14.29
1-Wochen-Bereich:
$13.09
$14.36
52-Wochen-Spanne:
$5.31
$14.36
Cryoport Inc Stock (CYRX) Company Profile
Firmenname
Cryoport Inc
Sektor
Telefon
(949) 232-1900
Adresse
112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
Compare CYRX vs FDX, UPS, JBHT, CHRW, EXPD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYRX
Cryoport Inc
|
13.92 | 705.63M | 176.18M | -36.26M | -28.09M | -0.9326 |
FDX
Fedex Corp
|
400.51 | 94.06B | 91.93B | 4.48B | 4.37B | 18.79 |
UPS
United Parcel Service Inc
|
102.20 | 85.87B | 88.37B | 5.25B | 4.52B | 6.1769 |
JBHT
J B Hunt Transport Services Inc
|
267.64 | 24.40B | 12.13B | 622.10M | 1.03B | 6.4596 |
CHRW
C H Robinson Worldwide Inc
|
178.03 | 20.54B | 16.20B | 599.01M | 807.11M | 4.9401 |
EXPD
Expeditors International Of Washington Inc
|
161.41 | 20.73B | 11.19B | 837.99M | 920.55M | 6.1898 |
Cryoport Inc Stock (CYRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-08-06 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-03-24 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-08-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-31 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-05-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-04-04 | Fortgesetzt | Jefferies | Buy |
| 2024-03-13 | Bestätigt | Needham | Buy |
| 2023-08-17 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-08-10 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-07-18 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-07-13 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2022-01-19 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-11-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-10-19 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-07-16 | Eingeleitet | BTIG Research | Buy |
| 2021-03-15 | Eingeleitet | UBS | Buy |
| 2021-03-02 | Fortgesetzt | Needham | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-07-01 | Fortgesetzt | Needham | Buy |
| 2018-10-10 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-13 | Bestätigt | Cowen | Outperform |
| 2018-07-02 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | Needham | Buy |
| 2017-11-30 | Eingeleitet | ROTH Capital | Buy |
| 2017-09-12 | Bestätigt | Cowen | Outperform |
| 2017-08-31 | Bestätigt | Needham | Buy |
| 2017-08-09 | Bestätigt | Cowen | Outperform |
| 2017-07-26 | Bestätigt | Needham | Buy |
| 2017-07-12 | Eingeleitet | Janney | Buy |
| 2017-06-16 | Eingeleitet | Cowen | Outperform |
| 2017-06-01 | Bestätigt | Needham | Buy |
| 2017-04-03 | Eingeleitet | Needham | Buy |
Alle ansehen
Cryoport Inc Aktie (CYRX) Neueste Nachrichten
CryoPort Analyst Ratings and Price Targets | NASDAQ:CYRX - Benzinga
Investors Buy High Volume of CryoPort Call Options (NASDAQ:CYRX) - MarketBeat
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Redwire (RDW) and CryoPort (CYRX) - The Globe and Mail
CYRX Maintained by Keybanc -- Price Target Raised to $17.00 - GuruFocus
Cryoport Is Maintained at Overweight by Keybanc - Moomoo
KeyBanc raises CryoPort stock price target to $17 on growth outlook By Investing.com - Investing.com South Africa
KeyBanc raises CryoPort stock price target to $17 on growth outlook - Investing.com
Cryoport Earnings Call Highlights Growth and Near-Term Caution - TipRanks
Understanding Momentum Shifts in (CYRX) - Stock Traders Daily
Cryoport Inc stock (US2289031005): earnings update keeps focus on biotech logistics growth - AD HOC NEWS
Cryoport Powers Cell Therapy Boom, Eyes Profitability Amid Record Growth - BriefGlance
Cryoport Inc stock (US2289031005): Q1 revenue beats estimates in volatile cell and gene logistics ma - AD HOC NEWS
CryoPort, Inc. $CYRX Shares Acquired by UBS Group AG - MarketBeat
CYRX | CryoPort, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
CryoPort, Inc.Common Stock (NQ: CYRX - FinancialContent
Cryoport Inc stock (US2289031005): Short interest drops to 4.86% as of April 30 - AD HOC NEWS
Cryoport posts revenue beat in Q1 as clinical trial support hits all-time high — 'A strong start to 2026' - MSN
Number of shareholders of CryoPort, Inc. – NASDAQ:CYRX - TradingView
Cryoport projects $192M-$196M FY 2026 revenue and expects positive adjusted EBITDA in 2H 2026 - MSN
CryoPort (NASDAQ:CYRX) Upgraded at Wall Street Zen - MarketBeat
Cryoport (CYRX) Q1 2025 Earnings Transcript - AOL.com
Roth MKM Maintains Cryoport(CYRX.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Cryoport stock is a buy, this analyst says - Cantech Letter
Analysts Conflicted on These Industrial Goods Names: CryoPort (CYRX) and Thomson Reuters (TRI) - The Globe and Mail
CryoPort Q1 2026 earnings preview - MSN
Cryoport Is Maintained at Buy by Guggenheim - Moomoo
CryoPort, Inc. (CYRX) reports Q1 loss, tops revenue estimates - MSN
Cryoport (CYRX) Q2 2025 Earnings Transcript - AOL.com
Analysts Offer Insights on Industrial Goods Companies: V2X (VVX) and CryoPort (CYRX) - The Globe and Mail
Analysts’ Top Industrial Goods Picks: Union Pacific (UNP), CryoPort (CYRX) - The Globe and Mail
CryoPort (NASDAQ:CYRX) Hits New 12-Month High on Analyst Upgrade - MarketBeat
Cryoport Inc. Signals Growth Momentum in Earnings Call - TipRanks
Cryoport | 10-Q: Q1 2026 Earnings Report - Moomoo
Cryoport, Inc. 1Q 2026: Revenue $47.8M, EPS ($0.25) — 10-Q Summary - TradingView
Cryoport (CYRX) lifts Q1 2026 revenue to $47.8M while trimming net loss - Stock Titan
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026' - Sahm
CryoPort (NASDAQ:CYRX) Shares Gap Up on Analyst Upgrade - MarketBeat
MoCo Minute | Biotechnology company CaleoBio advancing stem cell-based research - AOL.com
Cryoport price target raised to $17 from $15 at BTIG - TipRanks
Cryoport Lifts Guidance, HSBC Misses on Fraud Charge - Gotrade
CryoPort (NASDAQ:CYRX) Price Target Raised to $15.00 - MarketBeat
Cryoport | 8-K: Cryoport Reports First Quarter 2026 Financial Results - Moomoo
Needham Maintains Cryoport(CYRX.US) With Buy Rating, Raises Target Price to $15 - Moomoo
Guggenheim Maintains Cryoport(CYRX.US) With Buy Rating, Raises Target Price to $12 - Moomoo
CryoPort (NASDAQ:CYRX) Price Target Raised to $17.00 - MarketBeat
Cryoport Price Target Raised to $12.00/Share From $11.00 by Guggenheim - Moomoo
Cryoport price target raised to $12 from $11 at Guggenheim - TipRanks
Cryoport, Inc. (NASDAQ:CYRX) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Maintains Cryoport(CYRX.US) With Buy Rating, Raises Target Price to $17 - Moomoo
Needham raises CryoPort stock price target to $15 on revenue beat By Investing.com - Investing.com South Africa
Needham raises CryoPort stock price target to $15 on revenue beat - Investing.com Australia
Finanzdaten der Cryoport Inc-Aktie (CYRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cryoport Inc-Aktie (CYRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SHELTON JERRELL | President, CEO |
Apr 06 '26 |
Option Exercise |
1.87 |
50,000 |
93,500 |
1,126,607 |
| STEFANOVICH ROBERT | Chief Financial Officer |
Mar 23 '26 |
Sale |
8.18 |
1,094 |
8,949 |
279,277 |
| SHELTON JERRELL | President, CEO |
Mar 23 '26 |
Option Exercise |
1.87 |
25,000 |
46,750 |
1,076,607 |
| SHELTON JERRELL | President, CEO |
Mar 23 '26 |
Sale |
8.18 |
2,894 |
23,673 |
1,051,607 |
| Sawicki Mark W | Chief Scientific Officer |
Mar 23 '26 |
Sale |
8.18 |
1,341 |
10,969 |
102,356 |
| ZECCHINI EDWARD J | See Remarks |
Mar 16 '26 |
Sale |
8.00 |
2,014 |
16,112 |
109,719 |
| SHELTON JERRELL | President, CEO |
Mar 16 '26 |
Sale |
8.00 |
7,918 |
63,344 |
1,054,501 |
| Sawicki Mark W | Chief Scientific Officer |
Mar 16 '26 |
Sale |
8.00 |
3,235 |
25,880 |
103,697 |
| STEFANOVICH ROBERT | Chief Financial Officer |
Mar 12 '26 |
Option Exercise |
1.87 |
87,188 |
163,042 |
294,401 |
| STEFANOVICH ROBERT | Chief Financial Officer |
Mar 12 '26 |
Sale |
7.76 |
38,700 |
300,386 |
255,701 |
0.56%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):